JP2023548471A5 - - Google Patents
Info
- Publication number
- JP2023548471A5 JP2023548471A5 JP2023526126A JP2023526126A JP2023548471A5 JP 2023548471 A5 JP2023548471 A5 JP 2023548471A5 JP 2023526126 A JP2023526126 A JP 2023526126A JP 2023526126 A JP2023526126 A JP 2023526126A JP 2023548471 A5 JP2023548471 A5 JP 2023548471A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- sequence
- heavy chain
- light chain
- variable light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063108158P | 2020-10-30 | 2020-10-30 | |
| US63/108,158 | 2020-10-30 | ||
| US202063108791P | 2020-11-02 | 2020-11-02 | |
| US63/108,791 | 2020-11-02 | ||
| US202063112096P | 2020-11-10 | 2020-11-10 | |
| US63/112,096 | 2020-11-10 | ||
| US202163190097P | 2021-05-18 | 2021-05-18 | |
| US63/190,097 | 2021-05-18 | ||
| PCT/US2021/057452 WO2022094343A1 (en) | 2020-10-30 | 2021-10-29 | Anti-sars-cov-2 antigen antibodies and related compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548471A JP2023548471A (ja) | 2023-11-17 |
| JP2023548471A5 true JP2023548471A5 (enExample) | 2024-11-05 |
Family
ID=81384373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526126A Pending JP2023548471A (ja) | 2020-10-30 | 2021-10-29 | 抗ＳＡＲＳ－ＣｏＶ－２抗原抗体並びに関連する組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230382979A1 (enExample) |
| EP (1) | EP4237443A4 (enExample) |
| JP (1) | JP2023548471A (enExample) |
| AU (1) | AU2021369409A1 (enExample) |
| BR (1) | BR112023008365A2 (enExample) |
| CA (1) | CA3200263A1 (enExample) |
| IL (1) | IL302460A (enExample) |
| WO (1) | WO2022094343A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120981481A (zh) * | 2023-01-10 | 2025-11-18 | 萨那生物技术股份有限公司 | Cd19特异性抗体构建体以及它们的组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3538557A4 (en) * | 2016-11-08 | 2020-11-18 | Ablexis, LLC | ANTI-CD47 ANTIBODY |
| WO2019075433A1 (en) * | 2017-10-13 | 2019-04-18 | Adimab, Llc | ANTIBODIES AGAINST SYNCYTIAL RESPIRATORY VIRUS AND METHODS FOR THEIR GENERATION AND USE |
| CR20220552A (es) * | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
-
2021
- 2021-10-29 AU AU2021369409A patent/AU2021369409A1/en not_active Abandoned
- 2021-10-29 BR BR112023008365A patent/BR112023008365A2/pt unknown
- 2021-10-29 US US18/034,134 patent/US20230382979A1/en not_active Abandoned
- 2021-10-29 EP EP21887675.3A patent/EP4237443A4/en not_active Withdrawn
- 2021-10-29 CA CA3200263A patent/CA3200263A1/en active Pending
- 2021-10-29 IL IL302460A patent/IL302460A/en unknown
- 2021-10-29 WO PCT/US2021/057452 patent/WO2022094343A1/en not_active Ceased
- 2021-10-29 JP JP2023526126A patent/JP2023548471A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11891444B2 (en) | Variable regions for NKp46 binding proteins | |
| JP2024050548A (ja) | Ｃｄ４７に対するヒト化及びキメラモノクローナル抗体 | |
| US20250282879A1 (en) | Multispecific antibodies having specificity for il-4r and il-31 | |
| JP2022523507A5 (enExample) | ||
| US20240392003A1 (en) | Multispecific antibodies having specificity for ror1 and cd3 | |
| JP2023527609A5 (enExample) | ||
| JP2022548043A5 (enExample) | ||
| JP2023549537A5 (enExample) | ||
| US11365240B2 (en) | Anti-HSA antibodies | |
| TW202212355A (zh) | 多特異性抗體及其用途、用於產生其之方法、包括其之藥物組合物、編碼其之核酸序列、包括核酸序列的載體及包括載體的宿主細胞 | |
| JP2021530244A5 (enExample) | ||
| JP2023536631A5 (enExample) | ||
| JP2025506341A5 (enExample) | ||
| JP2023512827A5 (enExample) | ||
| IL297444A (en) | Humanized antibodies against complement factor bb and their use | |
| US20230203162A1 (en) | Multispecific antibody | |
| JP2023536630A5 (enExample) | ||
| JP2022541192A5 (enExample) | ||
| US20250382363A1 (en) | Antibody Variable Domains And Antibodies Having Decreased Immunogenicity | |
| JP2022544068A5 (enExample) | ||
| CA3143957A1 (en) | Anti-pd-l1 antibodies | |
| EP4273162A1 (en) | Antibody variable domains and antibodies having decreased immunogenicity | |
| TW202415677A (zh) | 抗TNFα抗體及組合物 | |
| JP2025503176A5 (enExample) | ||
| WO2023143273A1 (zh) | 新型长效化和高活性且更安全的抗体构建体 |